Kennedy’s mRNA cuts challenge Trump’s Warp Speed achievementsnews2025-08-07T19:12:56+00:00August 7th, 2025|Endpoints News|
New FDA program aims to speed up construction of US manufacturing sites news2025-08-07T15:45:47+00:00August 7th, 2025|Endpoints News|
Scholar Rock expects September PDUFA for spinal muscular atrophy drug to stay unchanged despite CDMO woes news2025-08-07T13:16:44+00:00August 7th, 2025|Endpoints News|
Merck’s infant RSV antibody gets CDC’s recommendationnews2025-08-07T13:13:15+00:00August 7th, 2025|Endpoints News|
FDA approves targeted brain cancer drug from Jazz’s Chimerix buyout news2025-08-06T19:43:30+00:00August 6th, 2025|Endpoints News|
Novavax expects Phase 4 Covid trial to cost up to $90Mnews2025-08-06T18:05:52+00:00August 6th, 2025|Endpoints News|
Makary has asked Prasad to ‘reconsider’ departure from FDAnews2025-08-05T18:25:32+00:00August 5th, 2025|Endpoints News|
Replimune says it’s waiting for FDA on a path forward for rejected cancer treatmentnews2025-08-01T19:33:28+00:00August 1st, 2025|Endpoints News|
CMS considers pilot plan for covering weight loss drugs — reportnews2025-08-01T19:02:02+00:00August 1st, 2025|Endpoints News|
FDA requires opioid label updates to highlight long-term risksnews2025-08-01T16:19:30+00:00August 1st, 2025|Endpoints News|